Clinical Trials
As an infrastructure at the German Center for Infection Research (DZIF), the Clinical Trial Unit tracks DZIF's study activities in the “Healex Site Management System (SMS)”. Studies are sorted by indication and are continuously updated.
The study register has recently been expanded to include the category “COVID-19”. For the first time, not only DZIF study activities are presented here: In order to provide a comprehensive overview in the current pandemic situation of planned and already active COVID-19 studies in Germany, the Clinical Trial Unit is cooperating with researchers from various German Centers for Health Research and other networks.
For researchers: If your study is not yet included in our portal, please contact the project management of the Clinical Trial Unit.
MK-1439-007
- Overall study
- Study Sites (1)
Hannover
MHH - Medizinische Hochschule Hannover
Address
Carl-Neuberg-Str. 1
D-30625 Hannover
Study office
DZIF-CTU Hannover
- Tel. 049 511 532 3531
- Fax 049 532 532 3353
- Welte.Tobias@mh-hannover.de
MHH Klinik für Immunologie und Rheumatologie
- Tel. +49-511-532-6656
- Fax +49-511-532-9067
- immunologie@mh-hannover.de
Status
Active
Principal Investigator
Prof. Dr. med. Matthias Stoll
Subinvestigator
- Dr. Gerrit Ahrenstorf
- Prof. Dr. Georg Behrens
Contact at Site
- Prof. Dr. med. Reinhold E. Schmidt
- Tel. +49 (0)511 532 6656
- Fax +49 (0)511 532 9067
- Schmidt.Reinhold.Ernst@mh-hannover.de